Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On July 1, ...

The second season of the Namugongo League continues to be more than just a football tournament. Match day two was held on ...

CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...

A study by the Centre for Policy Impact in Global Health revealed that over 30 per cent of people with SCD in Nigeria ...

Sickle cell disease is one of the most common genetic blood disorders in the world. It affects millions globally, with the ...

"Vertex reports long-term results for Casgevy in sickle cell and thalassaemia" was originally created and published by ...

As a result of being a caregiver for her cousin, columnist Sylvia Amuta says she's now more caring, compassionate, and kind to others.

Sickle cell disease affects about 100,000 people in the U.S., and 90% of patients are Black, according to NIH.

Genetics reunited the families of Argentina’s disappeared. President Javier Milei’s government is imperiling that.

Vertex Pharmaceuticals unveiled impressive long-term results for its CRISPR/Cas9 gene therapy, PrCASGEVY, at the EHA Congress ...

Higher pain scores upon discharge from the emergency department may predict hospitalization in adolescents with SCD, a study ...

Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.